Trial Information

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

Subjects are healthy adult volunteers either at high risk for HIV infection or already known
to be seropositive, who will donate blood for in vitro tests of T-cell function and in vitro
responses to synthetic peptides corresponding to sequences from HIV proteins.